Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...
Streetwise Reports | April 13, 2020 |

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study

Shares of Edesa Biotech traded more than 100% higher after the company reported that it had received regulatory approval from Health Canada to initiate a Phase 2/3 study of its investigational drug EB05 in COVID-19. Clinical-stage biopharmaceutical company Edesa B...
Streetwise Reports | June 16, 2020 |

High-Grade Values; Preliminary Exploration Across Multiple Properties

(Click the image to read the report.) Market research firm Fundamental Research Corp. recently initiate coverage into Falcon Gold Corp. ( TSX-V: FG ) labelling the Canadian mineral exploration company as a “buy”. Falcon Gold is build...
Fundamental Research | October 26, 2020 |

VIDEO: Focused On Past Producing Gold Mines in Quebec

Philippe Cloutier, President & CEO of Cartier Resources discusses how the companies main focus is exploring for gold in the Abitibi Greenstone Belt. “Our main focus is gold. Exploring for gold in the Abitibi Greenstone Belt, the Quebec portion ...
BTV-Business Television | April 22, 2019 |

Is Britain At The Edge Of A Political Cliff?

Recent news that Theresa May was unable to convince members of Parliament to even consider her current deal as well as the future political and societal consequences of any failure to move ahead with an orderly Brexit deal. The question before traders and investors is how will...
Chris Vermeulen | March 13, 2019 |

August 19 (Crazy Ivan) Event Only A Few Days Away

Our researchers have created this research post to highlight a big price move based on super-cycle research and patterns that should begin on or near August 19, 2019. Back in April/May 2019, we started warning of a critical top formation we believed was aligned for July 2019. ...
Chris Vermeulen | August 14, 2019 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |

Medigene, Memphasys, Qiagen - which stocks belong in the portfolio?

In times of price fluctuations, so-called 'buy on dips' strategy can be an effective method of achieving a favorable entry price for listed companies. Global trends as a framework can be decisive for a successful investment decision. For a modern society, the healthcare sector...
Mario Hose | March 4, 2020 |

Draegerwerk or Micro-X - how do investors benefit from the Corona Pandemic?

The current Corona Pandemic is challenging people around the globe. Doctors and medical staff are under particular strain. For some time now, it has become clear that there is a lack of material and equipment to withstand a large onslaught of infected Covid-19 patients. In ord...
Mario Hose | March 27, 2020 |
1 2 3 4 5 6 7 8 9